Stay updated on Dengue Attenuated Vaccine Safety & Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the Dengue Attenuated Vaccine Safety & Immunogenicity Clinical Trial page.

Latest updates to the Dengue Attenuated Vaccine Safety & Immunogenicity Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record is displayed with details on the phase II dengue vaccine study, including study design, participant eligibility, locations, interventions, and measured outcomes.SummaryDifference53%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the terminology transition from “artificial intelligence” to “Super Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer’s revision identifier advances from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now renders a 403 Forbidden error page with a basic header and footer, replacing the previous study details. This blocks access to the study’s description, locations, eligibility, and other related information.SummaryDifference19%

Stay in the know with updates to Dengue Attenuated Vaccine Safety & Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dengue Attenuated Vaccine Safety & Immunogenicity Clinical Trial page.